Planta Med 2014; 80(02/03): 183-186
DOI: 10.1055/s-0033-1360262
Biological and Pharmacological Activity
Letters
Georg Thieme Verlag KG Stuttgart · New York

In Vitro and In Vivo Studies of Trypanocidal Activity of Dietary Isothiocyanates

Dietmar Steverding
1   BioMedical Research Centre, Norwich Medical School, University of East Anglia, Norwich, United Kingdom
,
Sarah Michaels
1   BioMedical Research Centre, Norwich Medical School, University of East Anglia, Norwich, United Kingdom
,
Kevin D. Read
2   Drug Discovery Unit, Division of Biological Chemistry & Drug Discovery, College of Life Sciences, University of Dundee, Dundee, United Kingdom
› Author Affiliations
Further Information

Publication History

received 29 July 2013
revised 03 December 2013

accepted 04 December 2013

Publication Date:
22 January 2014 (online)

Abstract

Six dietary isothiocyanates, allyl-isothiocyanate, benzyl-isothiocyanate, phenylethyl-isothiocyanate, sulforaphane, erucin, and iberin, were tested for their trypanocidal activities in vitro using culture-adapted bloodstream forms of Trypanosoma brucei. All isothiocyanates showed a dose-dependent effect on the growth of trypanosomes. Five compounds displayed MIC values of 10 µM and GI50 values of around 1.5 µM, while allyl-isothiocyanate exhibited values of 100 and 11 µM, respectively. The compounds showed similar cytotoxic activities against human HL-60 cells with GI50 values of 1–4 µM and MIC values of 10–100 µM. Short-term experiments revealed that, with the exception of allyl-isothiocyanate, isothiocyanates at a concentration of 10 µM kill trypanosomes within 1–4 h of incubation. In contrast, HL-60 cells were not affected by any of the compounds in short-term incubation experiments. Sulforaphane, the most intensively studied isothiocyanate, was also investigated for its in vivo trypanocidal activity. However, administration of 50 mg/kg sulforaphane orally or intraperitoneally for four days had no effect on the parasitaemia in mice infected with T. brucei compared to control animals treated with vehicle alone.

 
  • References

  • 1 Steverding D. The history of African trypanosomiasis. Parasit Vectors 2008; 1: 3
  • 2 WHO. Trypanosomiasis, human African (sleeping sickness). Geneva: World Health Organ Fact Sheet 2013.; 259 Available at http://www.who.int/mediacentre/factsheets/fs259/en/ Accessed October 10, 2013
  • 3 Kristjanson PM, Swallow BM, Rowlands GJ, Kruska RL, de Leeuw PN. Measuring the costs of African animal trypanosomiasis, the potential benefits of control and returns to research. Agric Syst 1999; 59: 79-98
  • 4 Delespaux V, de Koning HP. Drugs and drug resistance in African trypanosomiasis. Drug Resist Updat 2007; 10: 30-50
  • 5 Matovu E, Seebeck T, Enyaru JC, Kaminsky R. Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle. Microbes Infect 2001; 3: 763-770
  • 6 Hannaert V. Sleeping sickness pathogen (Trypanosoma brucei) and natural products: therapeutic targets and screening systems. Planta Med 2011; 77: 586-597
  • 7 Zhang Y, Yao S, Li J. Vegetable-derived isothiocyanates: anti-proliferative activity and mechanism of action. Proc Nutr Soc 2006; 65: 68-75
  • 8 Deterding A, Dungey FA, Thompson KA, Steverding D. Anti-trypanosomal activities of DNA topoisomerase inhibitors. Acta Trop 2005; 93: 311-316
  • 9 Nkemgu-Njinkeng J, Rosenkranz V, Wink M, Steverding D. Antitrypanosomal activities of proteasome inhibitors. Antimicrob Agents Chemother 2002; 46: 2038-2040
  • 10 Steverding D, Wang X. Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib. Parasit Vectors 2009; 2: 29
  • 11 Jakubikova J, Bao Y, Sedlak J. Isothiocyanates induce cell cycle arrest, apoptosis and mitochondrial potential depolarization in HL-60 and multidrug-resistant cell lines. Anticancer Res 2005; 25: 3375-3386
  • 12 Ohta Y, Takatani K, Kawakishi S. Decomposition rate of allyl isothiocyanate in aqueous solution. Biosci Biotechnol Biochem 1995; 59: 102-103
  • 13 Veeranki OL, Bhattacharya A, Marshall JR, Zhang Y. Organ-specific exposure and response to sulforaphane, a key chemopreventive ingredient in broccoli: implication for cancer prevention. Br J Nutr 2013; 109: 25-32
  • 14 Hirumi H, Hirumi K, Doyle JJ, Cross GAM. In vitro cloning of animal-infective bloodstream forms of Trypanosoma brucei . Parasitology 1980; 80: 371-382
  • 15 Saha S, Hollands W, Teucher B, Needs PW, Narbad A, Ortori CA, Barrett DA, Rossiter JT, Mithen RF, Kroon PA. Isothiocyanate concentrations and interconversion of sulforaphane to erucin in human subjects after consumption of commercial frozen broccoli compared to fresh broccoli. Mol Nutr Food Res 2012; 56: 1906-1916
  • 16 Gamet-Pyrastre L. Signaling pathways and intracellular targets of sulforaphane mediating cell cycle arrest and apoptosis. Curr Cancer Drug Targets 2006; 6: 135-145
  • 17 Steverding D, Sexton DW. Trypanocidal activity of salinomycin is due to sodium influx followed by cell swelling. Parasit Vectors 2013; 6: 78
  • 18 Collins SR, Gallo RC, Gallagher RE. Continuous growth and differentiation of human myeloid leukaemic cells in suspension cultures. Nature 1997; 270: 347-349
  • 19 Baltz T, Baltz D, Giroud C, Crockett J. Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense . EMBO J 1985; 4: 1273-1277
  • 20 Moore GE, Gerner RE, Franklin HA. Culture of normal human leukocytes. J Am Med Assoc 1967; 199: 519-524
  • 21 Steverding D, Baldisserotto A, Wang X, Marastoni M. Trypanocidal activity of peptidyl vinyl ester derivatives selective for inhibition of mammalian proteasome trypsin-like activity. Exp Parasitol 2011; 128: 444-447
  • 22 Sebaugh JL. Guidelines for accurate EC50/IC50 estimation. Pharm Stat 2011; 10: 128-134
  • 23 Herbert WJ, Lumsden WHR. Trypanosoma brucei: a rapid “matching” method for estimating the hostʼs parasitemia. Exp Parasitol 1976; 40: 427-431